Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.6.0.2
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Operating expenses:        
Research and development $ 254,105 $ 2,118,204 $ 618,257 $ 4,983,790
General and administrative 1,282,296 3,604,109 2,534,740 5,368,122
Total Operating Expenses 1,536,401 5,722,313 3,152,997 10,351,912
Loss from Operations (1,536,401) (5,722,313) (3,152,997) (10,351,912)
Other income (expenses):        
Change in fair value of derivative liabilities 449,041 3,261,980 368,998 12,555,319
Net interest (expense) (378) (329) (1,229) (927)
Other income 56,909 113,818
Total other income (expenses) 505,572 3,261,651 481,587 12,554,392
Net (Loss) Income $ (1,030,829) $ (2,460,662) $ (2,671,410) $ 2,202,480
Net (Loss) Income per common share - basic $ (0.09) $ (0.22) $ (0.22) $ 0.2
Net (Loss) Income per common share - diluted $ (0.09) $ (0.22) $ (0.22) $ 0.19
Weighted Average Number of Shares Outstanding, Basic [Abstract]        
Basic 12,035,912 11,420,179 12,035,625 11,184,064
Diluted 12,035,912 11,420,179 12,035,625 11,856,985